[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349111-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349111-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nop2-mediated-5-methylcytosine-regulates-lipid-metabolism-reprogramming-to-prime-tumors-for-ferroptosis-in-bladder-cancer-progression","NOP2-mediated 5-methylcytosine Regulates Lipid Metabolism Reprogramming to Prime Tumors for Ferroptosis in Bladder Cancer Progression","","RNA 5-methylcytosine (m5C) is an emerging epitranscriptomic modification implicated in cancer progression, but its landscape and regulation in bladder cancer remain unclear. This study identifies NOP2, an RNA methyltransferase, as a driver of bladder cancer progression, showing NOP2 upregulation and poor prognosis. Mechanistically, NOP2-mediated m5C recruits the m5C reader YBX1 to stabilize SCD mRNA and increase SCD expression, reprogramming lipid metabolism and reducing lipid peroxidation to evade ferroptotic stress.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nop2-mediated-5-methylcytosine-regulates-lipid-metabolism-reprogramming-to-prime-tumors-for-ferroptosis-in-bladder-cancer-progression/349111/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nop2-mediated-5-methylcytosine-regulates-lipid-metabolism-reprogramming-to-prime-tumors-for-ferroptosis-in-bladder-cancer-progression/349111.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study in bladder cancer progression?","Question",{"text":63,"@type":64},"The study investigates how RNA 5-methylcytosine (m5C) regulation contributes to bladder cancer progression, identifying NOP2 as a key driver.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NOP2 affect lipid metabolism and ferroptosis sensitivity?",{"text":68,"@type":64},"NOP2-mediated m5C recruits YBX1 to stabilize SCD mRNA, increasing SCD expression and reshaping lipid composition to suppress lipid peroxidation, thereby protecting cells from ferroptotic stress.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does the NOP2/SCD axis play in tumor growth?",{"text":72,"@type":64},"The NOP2/SCD axis promotes tumor growth in xenograft models and its suppression impairs tumor progression and increases sensitivity of bladder cancer cells to cisplatin.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349111,1790790628,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(8): 4399-4416. doi: 10.7150/ijbs.126325  \nResearch Paper  \nNOP2-mediated 5-methylcytosine Regulates Lipid Metabolism Reprogramming to Prime Tumors for Ferroptosis in Bladder Cancer Progression  \nCheng Cheng1,2*, Jianguo Gao3,4*, Runzhe Wang1,2*, Yunfei Wu1,2, Yupeng Wang1,2, Baiye Jin1,2􀀍, Guanghou Fu1,2􀀍  \n1. Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.  \n2. Zhejiang Engineering Research Center for Urinary Bladder Carcinoma Innovation Diagnosis and Treatment, Hangzhou 310024, China.  \n3. Department of Urology, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China.  \n4. Huzhou Key Laboratory of Precise Diagnosis and Treatment of Urinary Tumors, Huzhou, Zhejiang, China.  \n* These authors contributed equally to this work.  \n􀀍 Corresponding authors: Baiye Jin ([1189006@zju.edu.cn](1189006@zju.edu.cn)), Guanghou Fu ([fuguanghou@zju.edu.cn](fuguanghou@zju.edu.cn)) .  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.10.06; Accepted: 2026.03.03; Published: 2026.04.16  \nAbstract  \nRNA 5-methylcytosine (m5C) is an emerging epitranscriptomic modification implicated in the progression of multiple cancers, yet the landscape of m5C in bladder cancer (BCa) and underlying regulatory mechanisms remains largely elusive. In this study, we identified NOP2, an RNA methyltransferase, as a key driver of BCa progression. NOP2 was significantly upregulated in BCa tumors and associated with poor prognosis. Functionally, NOP2 promoted cell proliferation and invasion, enhancing tumor growth in xenograft models. Mechanistically, NOP2-mediated m5C deposition facilitates the recruitment of them5C reader YBX1, thereby stabilizing SCD mRNA and boosting SCD expression. The NOP2/SCD axis orchestrated lipid metabolism reprogramming, altering the distribution of saturated, monounsaturated, and polyunsaturated fatty acids to suppress lipid peroxidation and protect BCa cells from ferroptotic stress. Collectively, our findings determine the oncogenic role of the m5C methyltransferase NOP2 in BCa and reveal a novel NOP2/YBX1/SCD axis that links epitranscriptomic regulation, metabolic reprogramming and ferroptosis evasion, providing a new target for therapeutic intervention.  \nKeywords: NOP2; 5-methylcytosine; SCD; lipid metabolism reprograming; ferroptosis sensitivity.  \nIntroduction  \nBladder cancer (BCa) is a major global health burden with high incidence, frequent recurrence and low survival rates in advanced patients [1-3] . Although standard therapies for initial treatment involve surgery, chemotherapy, immunotherapy, and targeted agents, outcome for advanced diseases remains unfavorable, with a 5-year survival rate of 8% in metastatic cases [3]. Revealing the drivers of tumor development and metastasis is essential for improving treatment of BCa.  \nSubstantial evidence now establishes epitranscriptomic dysregulation and metabolism reprogramming as hallmarks of cancer [4-11] . A key focus of recent research has been the critical role of  \nRNA modification 5-methylcytosine (m5C) across a wide spectrum of cancers [5-8] . As a pivotal \"writer\"enzyme depositing m5C modifications on RNA, the methyltransferase NOP2 has been implicated in tumor progression [12, 13] . However, its specific role and mechanistic underpinnings in bladder cancer progression remain unclear.  \nReprogrammed lipid metabolism of cancer cell not only supplies cells energy, but also plays an important role in ferroptosis [9, 10] . Fatty acid desaturation serves multiple functions preventing lipo-toxicity, inhibiting ferroptosis, and regulati","cbCaib7P2qnIaKGa","https://ap.wps.com/l/cbCaib7P2qnIaKGa","pdf",9920643,18,"English","# Abstract\n# Introduction\n# Methods\n## Clinical specimens\n## Cell culture","[{\"question\":\"What is the main focus of the study in bladder cancer progression?\",\"answer\":\"The study investigates how RNA 5-methylcytosine (m5C) regulation contributes to bladder cancer progression, identifying NOP2 as a key driver.\"},{\"question\":\"How does NOP2 affect lipid metabolism and ferroptosis sensitivity?\",\"answer\":\"NOP2-mediated m5C recruits YBX1 to stabilize SCD mRNA, increasing SCD expression and reshaping lipid composition to suppress lipid peroxidation, thereby protecting cells from ferroptotic stress.\"},{\"question\":\"What role does the NOP2/SCD axis play in tumor growth?\",\"answer\":\"The NOP2/SCD axis promotes tumor growth in xenograft models and its suppression impairs tumor progression and increases sensitivity of bladder cancer cells to cisplatin.\"}]","NOP2-mediated 5-methylcytosine Regulates Lipid Metabolism Reprogramming to Prime Tumors for Ferroptosis in Bladder Cancer Progression | PDF",1790081703,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/939d3193a185d2585d2a9d8d7913a9ed.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5e4b40ca2c40a9b28be5769c30a821c.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7a5f3dbea96c07f473e47129bf58254.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce27ce6ce49232ea29c631b3eb74295a.webp",980,1268]